Schweizer et al. (1990) has shown that there was no significant difference in response rates if non-responders to fluoxetine at three weeks were randomized to either fluoxetine 20 mg/day or 60 mg/day for a further 5 weeks. This indicates that, at least in the first 8 weeks of treatment with fluoxetine, ‘tincture of time’ may be more important than dosage increase.
Ref: - Schweizer, E., Rickels, K., Amsterdam, J.D., et al. (1990) What constitutes an adequate antidepressant trial of fluoxetine? Journal of Clinical Psychiatry, 51, 8-11.
No Pingbacks for this post yet...
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
| << < | > >> | |||||
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 | |
This blog on Clinical Psychopharmacology is maintained by Dr. Shahul Ameen, M.D., Psychiatrist, St. John's Hospital, Kattappana, Idukki, Kerala, India.
Psychopharmacology Tips is a part of PsyPlexus, a portal for mental health professionals.
This blog is only for educational purpose of psychiatrists and other physicians. The information published in this blog is not intended for use as a substitute for consultation to a licensed health professional. Patients and consumers who visit Psychopharmacology Tips should carefully review the information gathered from the site with a professional healthcare provider.